196 related articles for article (PubMed ID: 22300836)
1. Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.
Delille HK; Becker JM; Burkhardt S; Bleher B; Terstappen GC; Schmidt M; Meyer AH; Unger L; Marek GJ; Mezler M
Neuropharmacology; 2012 Jun; 62(7):2184-91. PubMed ID: 22300836
[TBL] [Abstract][Full Text] [Related]
2. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
3. Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.
Albizu L; Holloway T; González-Maeso J; Sealfon SC
Neuropharmacology; 2011 Sep; 61(4):770-7. PubMed ID: 21645528
[TBL] [Abstract][Full Text] [Related]
4. Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells.
Baki L; Fribourg M; Younkin J; Eltit JM; Moreno JL; Park G; Vysotskaya Z; Narahari A; Sealfon SC; Gonzalez-Maeso J; Logothetis DE
Pflugers Arch; 2016 May; 468(5):775-93. PubMed ID: 26780666
[TBL] [Abstract][Full Text] [Related]
5. The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways.
Delille HK; Mezler M; Marek GJ
Neuropharmacology; 2013 Jul; 70():296-305. PubMed ID: 23466331
[TBL] [Abstract][Full Text] [Related]
6. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
[TBL] [Abstract][Full Text] [Related]
7. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Olivero G; Grilli M; Vergassola M; Bonfiglio T; Padolecchia C; Garrone B; Di Giorgio FP; Tongiani S; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2018 May; 133():429-439. PubMed ID: 29499271
[TBL] [Abstract][Full Text] [Related]
9. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.
Benneyworth MA; Xiang Z; Smith RL; Garcia EE; Conn PJ; Sanders-Bush E
Mol Pharmacol; 2007 Aug; 72(2):477-84. PubMed ID: 17526600
[TBL] [Abstract][Full Text] [Related]
10. Maternal lipopolysaccharide treatment differentially affects 5-HT(2A) and mGlu2/3 receptor function in the adult male and female rat offspring.
Wischhof L; Irrsack E; Dietz F; Koch M
Neuropharmacology; 2015 Oct; 97():275-88. PubMed ID: 26051401
[TBL] [Abstract][Full Text] [Related]
11. 5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.
Huang M; Dai J; Meltzer HY
Eur J Pharmacol; 2011 Feb; 652(1-3):40-5. PubMed ID: 21118683
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
[TBL] [Abstract][Full Text] [Related]
13. 5-HT
Murat S; Bigot M; Chapron J; König GM; Kostenis E; Battaglia G; Nicoletti F; Bourinet E; Bockaert J; Marin P; Vandermoere F
Mol Psychiatry; 2019 Nov; 24(11):1610-1626. PubMed ID: 29858599
[TBL] [Abstract][Full Text] [Related]
14. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
Moreno JL; Muguruza C; Umali A; Mortillo S; Holloway T; Pilar-Cuéllar F; Mocci G; Seto J; Callado LF; Neve RL; Milligan G; Sealfon SC; López-Giménez JF; Meana JJ; Benson DL; González-Maeso J
J Biol Chem; 2012 Dec; 287(53):44301-19. PubMed ID: 23129762
[TBL] [Abstract][Full Text] [Related]
15. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis.
Wischhof L; Koch M
Behav Pharmacol; 2016 Feb; 27(1):1-11. PubMed ID: 26292187
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.
Regina MJ; Bucelli RC; Winter JC; Rabin RA
Brain Res; 2004 Apr; 1003(1-2):168-75. PubMed ID: 15019576
[TBL] [Abstract][Full Text] [Related]
18. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.
Łukasiewicz S; Faron-Górecka A; Kędracka-Krok S; Dziedzicka-Wasylewska M
Eur J Pharmacol; 2011 Jun; 659(2-3):114-23. PubMed ID: 21496455
[TBL] [Abstract][Full Text] [Related]
19. The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy.
Naumenko VS; Bazovkina DV; Kondaurova EM; Zubkov EA; Kulikov AV
Genes Brain Behav; 2010 Jul; 9(5):519-24. PubMed ID: 20345894
[TBL] [Abstract][Full Text] [Related]
20. Selective and divergent regulation of cortical 5-HT(2A) receptors in rabbit.
Aloyo VJ; Dave KD; Rahman T; Harvey JA
J Pharmacol Exp Ther; 2001 Dec; 299(3):1066-72. PubMed ID: 11714896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
